The Company will identify and patent the active novel compound in a unique Amazon rainforest plant that has shown through extensive testing to be curative against brain, breast, prostrate, colorectal and luekemia cancers. Once the pre-clinical and clinical trials are perfrmed, the novel drug will be developed into internationally approved anti-cancer therapies. The world still has a great unmet need for curative, non-toxic oncology drugs.